China Universal Asset Management »

Puma Biotechnology shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Puma Biotechnology (PBYI) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Puma Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Puma Biotechnology held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Puma Biotechnology by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $49k 8.2k 5.95
2022-09-30 $999 426 2.35

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Puma Biotechnology

Acorn Capital Advisors
Vanguard Group
BlackRock
Renaissance Technologies
Acadian Asset Management
American Century Companies
Dimensional Fund Advisors
O'shaughnessy Asset Management
Geode Capital Management
State Street Corporation
Connor, Clark & Lunn Investment Management
Kennedy Capital Management
Goldman Sachs Group
Comprehensive Portfolio Management
Northern Trust

View all funds holding Puma Biotechnology